Norman L. Foster

21.6k total citations · 6 hit papers
154 papers, 15.4k citations indexed

About

Norman L. Foster is a scholar working on Psychiatry and Mental health, Physiology and Cognitive Neuroscience. According to data from OpenAlex, Norman L. Foster has authored 154 papers receiving a total of 15.4k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Psychiatry and Mental health, 45 papers in Physiology and 29 papers in Cognitive Neuroscience. Recurrent topics in Norman L. Foster's work include Dementia and Cognitive Impairment Research (72 papers), Alzheimer's disease research and treatments (40 papers) and Parkinson's Disease Mechanisms and Treatments (17 papers). Norman L. Foster is often cited by papers focused on Dementia and Cognitive Impairment Research (72 papers), Alzheimer's disease research and treatments (40 papers) and Parkinson's Disease Mechanisms and Treatments (17 papers). Norman L. Foster collaborates with scholars based in United States, Australia and Canada. Norman L. Foster's co-authors include Satoshi Minoshima, Kirk A. Frey, David E. Kuhl, Robert A. Koeppe, Stanley Berent, Bruno Giordani, William J. Jagust, Eric M. Reiman, Thomas N. Chase and Michael W. Weiner and has published in prestigious journals such as JAMA, PLoS ONE and NeuroImage.

In The Last Decade

Norman L. Foster

151 papers receiving 15.0k citations

Hit Papers

Metabolic reduction in the posterior cingulate cortex in ... 1995 2026 2005 2015 1997 1995 2006 2009 2009 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease
    1997 1.4k citations Satoshi Minoshima, Bruno Giordani et al. Annals of Neurology profile →
  2. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET.
    1995 826 citations Satoshi Minoshima, Kirk A. Frey et al. PubMed profile →
  3. The Uniform Data Set (UDS): Clinical and Cognitive Variables and Descriptive Data From Alzheimer Disease Centers
    2006 718 citations Norman L. Foster et al. Alzheimer Disease & Associated Disorders profile →
  4. The Alzheimer's Disease Centers' Uniform Data Set (UDS)
    2009 690 citations Norman L. Foster et al. Alzheimer Disease & Associated Disorders profile →
  5. Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI
    2009 544 citations Danielle Harvey, Robert A. Koeppe et al. profile →
  6. Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association
    2013 402 citations Keith A. Johnson, Satoshi Minoshima et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Norman L. Foster United States 60 7.8k 6.4k 4.0k 2.6k 2.5k 154 15.4k
Florence Pasquier France 65 8.8k 1.1× 6.7k 1.1× 3.4k 0.9× 3.6k 1.4× 1.5k 0.6× 362 19.1k
Ranjan Duara United States 59 6.3k 0.8× 5.3k 0.8× 3.8k 1.0× 2.2k 0.9× 1.6k 0.7× 302 13.8k
Alexander Kurz Germany 56 7.8k 1.0× 5.2k 0.8× 4.1k 1.0× 1.4k 0.5× 1.7k 0.7× 247 14.5k
Marilyn S. Albert United States 55 10.1k 1.3× 6.6k 1.0× 6.0k 1.5× 1.3k 0.5× 1.5k 0.6× 100 19.7k
Stefan Teipel Germany 72 7.3k 0.9× 6.8k 1.1× 5.7k 1.4× 1.8k 0.7× 3.8k 1.5× 441 17.1k
José Luís Molinuevo Spain 72 6.9k 0.9× 6.3k 1.0× 4.4k 1.1× 4.7k 1.8× 1.4k 0.6× 347 18.6k
Paul Maruff Australia 81 10.3k 1.3× 6.3k 1.0× 7.9k 2.0× 1.8k 0.7× 1.6k 0.6× 573 26.4k
Gil D. Rabinovici United States 69 9.4k 1.2× 9.9k 1.6× 6.1k 1.6× 3.1k 1.2× 3.0k 1.2× 316 18.4k
Charles DeCarli United States 90 9.5k 1.2× 6.6k 1.0× 4.3k 1.1× 3.1k 1.2× 3.8k 1.5× 447 23.9k
Hans Förstl Germany 66 5.4k 0.7× 3.9k 0.6× 4.9k 1.3× 2.0k 0.8× 1.4k 0.6× 399 14.2k

Countries citing papers authored by Norman L. Foster

Since Specialization
Citations

This map shows the geographic impact of Norman L. Foster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norman L. Foster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norman L. Foster more than expected).

Fields of papers citing papers by Norman L. Foster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norman L. Foster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norman L. Foster. The network helps show where Norman L. Foster may publish in the future.

Co-authorship network of co-authors of Norman L. Foster

This figure shows the co-authorship network connecting the top 25 collaborators of Norman L. Foster. A scholar is included among the top collaborators of Norman L. Foster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norman L. Foster. Norman L. Foster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schliep, Karen C., C. Elizabeth Shaaban, Huong Meeks, et al.. (2023). Hypertensive disorders of pregnancy and subsequent risk of Alzheimer's disease and other dementias. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 15(2). e12443–e12443. 8 indexed citations
2.
King, Jace B., et al.. (2020). Left Ear Hearing Predicts Functional Activity in the Brains of Patients with Alzheimer’s Disease Dementia. Annals of Otology Rhinology & Laryngology. 130(4). 343–349. 9 indexed citations
3.
Puig, Kendra L., Brianna Marie Lutz, Xudong Zhou, et al.. (2015). Overexpression of Mutant Amyloid-β Protein Precursor and Presenilin 1 Modulates Enteric Nervous System. Journal of Alzheimer s Disease. 44(4). 1263–1278. 58 indexed citations
4.
Duff, Kevin, Norman L. Foster, & John M. Hoffman. (2014). Practice Effects and Amyloid Deposition. Alzheimer Disease & Associated Disorders. 28(3). 247–252. 45 indexed citations
5.
Johnson, Keith A., Satoshi Minoshima, Nicolaas I. Bohnen, et al.. (2013). Update on Appropriate Use Criteria for Amyloid PET Imaging: Dementia Experts, Mild Cognitive Impairment, and Education. Journal of Nuclear Medicine. 54(7). 1011–1013. 62 indexed citations
6.
Wu, Xia, Kewei Chen, Li Yao, et al.. (2010). Assessing the reliability to detect cerebral hypometabolism in probable Alzheimer's disease and amnestic mild cognitive impairment. Journal of Neuroscience Methods. 192(2). 277–285. 13 indexed citations
7.
Banaszak‐Holl, Jane, A. Mark Fendrick, Norman L. Foster, et al.. (2004). Predicting Nursing Home Admission. Alzheimer Disease & Associated Disorders. 18(2). 83–89. 103 indexed citations
8.
Langa, Kenneth M., Eric B. Larson, Robert B. Wallace, et al.. (2004). Out-of-Pocket Health Care Expenditures Among Older Americans with Dementia. Alzheimer Disease & Associated Disorders. 18(2). 90–98. 25 indexed citations
9.
Bozoki, Andrea, Bruno Giordani, Judith L. Heidebrink, Stanley Berent, & Norman L. Foster. (2001). Mild Cognitive Impairments Predict Dementia in Nondemented Elderly Patients With Memory Loss. Archives of Neurology. 58(3). 411–6. 304 indexed citations
10.
Foster, Norman L., et al.. (1999). Breast and bottle feeding for mothers with arthritis and other physical disabilities. Coventry University Open Collections (Coventry university). 9(2). 35–38. 2 indexed citations
11.
Fisher, Nancy, Byron P. Rourke, Linas A. Bieliauskas, et al.. (1997). Unmasking the heterogeneity of alzheimer's disease: Case studies of individuals from distinct neuropsychological subgroups. Journal of Clinical and Experimental Neuropsychology. 19(5). 713–754. 16 indexed citations
12.
Fontana, Robert J., D. Kim Turgeon, Thomas F. Woolf, et al.. (1996). The Caffeine Breath Test Does Not Identify Patients Susceptible to Tacrine Hepatotoxicity. Hepatology. 23(6). 1429–1435. 16 indexed citations
13.
Murman, Daniel L., et al.. (1996). Apolipoprotein E and Alzheimer's Disease: Strength of Association Is Related to Age at Onset. Dementia and Geriatric Cognitive Disorders. 7(5). 251–255. 20 indexed citations
14.
Cochran, Elizabeth J., David A. Bennett, Larisa Červen̆áková, et al.. (1996). Familial Creutzfeldt-Jakob disease with a five-repeat octapeptide insert mutation. Neurology. 47(3). 727–733. 57 indexed citations
15.
Minoshima, Satoshi, Kirk A. Frey, Robert A. Koeppe, Norman L. Foster, & David E. Kuhl. (1995). A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET.. PubMed. 36(7). 1238–48. 826 indexed citations breakdown →
16.
Meyer, Michaël, Robert A. Koeppe, Kirk A. Frey, Norman L. Foster, & Dietmar Kuhl. (1995). Positron Emission Tomography Measures of Benzodiazepine Binding in Alzheimer's Disease. Archives of Neurology. 52(3). 314–317. 62 indexed citations
17.
Boivin, Michael J., Bruno Giordani, Stanley Berent, et al.. (1992). Verbal Fluency and Positron Emission Tomographic Mapping of Regional Cerebral Glucose Metabolism. Cortex. 28(2). 231–239. 71 indexed citations
18.
Grady, C. L., Alison M. Grimes, Nicholas J. Patronas, et al.. (1989). Divided Attention, as Measured by Dichotic Speech Performance, in Dementia of the Alzheimer Type. Archives of Neurology. 46(3). 317–320. 66 indexed citations
19.
Foster, Norman L., et al.. (1988). Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography. Annals of Neurology. 24(3). 399–406. 130 indexed citations
20.
LeWitt, Peter A., et al.. (1985). CSF dopamine‐‐hydroxylase activity in Parkinson's disease. Neurology. 35(4). 565–565. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Florence Pasquier Breakdown of academic impact, for papers by Ranjan Duara Breakdown of academic impact, for papers by Alexander Kurz Breakdown of academic impact, for papers by Marilyn S. Albert Breakdown of academic impact, for papers by Stefan Teipel Breakdown of academic impact, for papers by José Luís Molinuevo Breakdown of academic impact, for papers by Paul Maruff Breakdown of academic impact, for papers by Gil D. Rabinovici Breakdown of academic impact, for papers by Charles DeCarli Breakdown of academic impact, for papers by Hans Förstl
Rankless by CCL
2026